ÂÜÀòÂÒÂ×

Open Targets is an innovative, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. Open Targets brings together complimentary expertise of our academic and industry partners, Bristol Myers Squib... Read more